Alkem Laboratories Ltd - ALKEM LAB Share Price

Sector: Pharmaceuticals | ISIN: INE540L01014
₹ 3,822.10 (-7.71%) icon11 Aug, 2023, 3:58:37 PM
Open
₹ 4,100.50
Prev. Close
₹ 4,141.40
Turnover(lac)
₹ 35,967.83
Day's High
₹ 4,123.00
Day's Low
₹ 3,800.05
52 Wk High
₹ 4,243.00
52 Wk Low
₹ 2,855.00
Book Value
₹ 804.69
Face Value
₹ 2.00
Mkt. Cap (Cr.)
₹ 45,698.94
P/E
36.06
EPS
105.87
Div. Yield
1.31

Alkem Laboratories Ltd Stock View

info icon
Edit Image
HOLD
Target | 12 Aug, 2023 3,597.61 (-5.87%)

Alkem Laboratories Limited is an India-based company, which is engaged in the pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale ... Read More

Alkem Laboratories Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 8/11/2023 3:58:37 PM

    ₹ 3822.1 -319.30 -7.71
  • Open
  • ₹ 4,100.5
  • Prev. Close
  • ₹ 4,141.4
  • Turnover(Lac.)
  • ₹ 35,968
  • Day's High
  • ₹ 4,123
  • Day's Low
  • ₹ 3,800.05
  • 52 Week's High
  • ₹ 4,243
  • 52 Week's Low
  • ₹ 2,855
  • Book Value
  • ₹ 804.69
  • Face Value
  • ₹ 2
  • Mkt Cap (₹ Cr.)
  • 45,698.94
  • P/E
  • 36.06
  • EPS
  • 105.87
  • Divi. Yield
  • 1.31

Alkem Laboratories Ltd Corporate Actions

19 May , 2023

12:00 AM

Dividend

Dividend amount: 10
Announcement date: 19 May , 2023

View Details

31 Jul , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

31 Jul , 2023

12:00 AM

09 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

10 Feb , 2023

12:00 AM

Dividend

Dividend amount: 15
Announcement date: 10 Feb , 2023

View Details

10 Feb , 2023

12:00 AM

Dividend

Dividend amount: 25
Announcement date: 10 Feb , 2023

View Details

24 Jan , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

24 Jan , 2023

12:00 AM

02 Nov , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

02 Nov , 2022

12:00 AM

14 Sep , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

13 May , 2022

12:00 AM

AGM

Announcement date: 13 May , 2022

View Details

Alkem Laboratories Ltd News and Update

Image not found
  • 11 August, 2023 |
  • 7:25 PM

Recommendation: Buy; Target price: Rs 4400

Image not found
  • IIFL News Service |
  • 11 August, 2023 |
  • 7:25 PM
Image not found
Article Image
  • IIFL News Service |
  • 10 August, 2023 |
  • 7:24 PM

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Alkem Laboratories Ltd SHAREHOLDING SNAPSHOT
14 August , 2023 | 08:04 AM

PROMOTER - TOTAL57.16%

Indian: 57.16%

Foreign: 0%

NON-PROMOTER - TOTAL 42.84%

Institutions: 21.98%

Non-Institutions: 20.86%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Alkem Laboratories Ltd FINANCIALS

Alkem Laboratories Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Alkem Laboratories Ltd

  • Basudeo N Singh
  • Executive Chairman
  • SANDEEP SINGH
  • Managing Director
  • Mritunjay Kumar Singh
  • Executive Director
  • A K Purwar
  • Non-Exec. & Independent Dir.
  • SANGEETA KAPILJIT SINGH
  • Non-Exec. & Independent Dir.
  • SUDHA RAVI
  • Non-Exec. & Independent Dir.
  • Manish Narang
  • Company Sec. & Compli. Officer
  • Dheeraj Sharma
  • Non-Exec. & Independent Dir.
  • Narendra Aneja
  • Non-Exec. & Independent Dir.
  • SARVESH SINGH
  • Executive Director
  • Madhurima Singh
  • Executive Director
  • Sujjain Talwar
  • Independent Director
  • Srinivas Singh
  • Executive Director

Summary

Headquartered in Mumbai, India, Alkem Laboratories Limited is a leading Indian pharmaceutical company with global operations. The company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals, which it markets in India and international markets. With a portfolio of more than 800 brands in India, Alkem is ranked the fifth largest pharmaceutical company in India in terms of domestic sales. The company also has presence in more than 40 international markets, with the United States being its key focus market. Alkem Laboratories Ltd was incorporated as a private limited company on August 8, 1973 at Patna under the Companies Act, 1956 and subsequently became a deemed public limited company under section 43A(2) of Companies Act, 1956 on October 26, 1988. Pursuant to Company passing a resolution under section 21 of Companies Act, 1956 and upon issuance of a fresh certificate of incorporation consequent on change of name dated August 21, 2001, the name of Company was changed to Alkem Laboratories Limited with effect from October 26, 1988.In 1978, the company established its first plant at Taloja Maharashtra. In 1992, the company established its manufacturing facility in Mandwa, Maharashtra, which was later converted into an API facility in 2005. In 2003, the company set up a research and development facility for ANDA development... Read More


Reports by Alkem Laboratories Ltd


Reports by Alkem Laboratories Ltd

Company FAQ

No Record Found